The Company ended its last session at $10.89 by Declining -2.24%. The Average Volume Traded by the company in the last trading session is at 1.37 Million. Its 52-week High Value is $12.74 while its 52-week Low value is $4.26. The company has its outstanding Shares of 27.28 Million. The Stock shows P/E value of 0 and Forward P/E of 0.
Market capitalization is the total market value of all of a company’s outstanding shares. Market capitalization is calculated by multiplying a company’s shares outstanding by the current market price of one share. The investment community uses this figure to determine a company’s size, as opposed to sales or total asset figures. Cara Therapeutics Inc. (NASDAQ:CARA) has the market capitalization of 297.11 Million.
The (Simple Month Average) SMA20 is at 12.22 percent, its SMA50 Value is 15.47% and SMA200 value is reported as 53.91 Percent. The stock is currently showing its Return on Assets (ROA) value of -46.6 Percent. The Return on Equity (ROE) and Return on Investment values are -50.6 percent and -23.5 percent respectively.
Cara Therapeutics Inc. (NASDAQ:CARA) has its dividend (annual) of 0 while its Dividend Yield (annual) is 0%. A dividend is a distribution of a portion of a company’s earnings decided by its BOD (board of directors) specifically for its shareholders. Dividends are mostly given in terms of cash payments, property or as shares of stock.
If we look at the Volatility of the company, Week Volatility is 6.81%, whereas Month Volatility is at 6.56%. The ATR (Average True Range) value is 0.66.
Year to date (YTD) refers to the period beginning the first day of the current calendar or fiscal year up to the current date. YTD information is useful for analyzing business trends or comparing performance data, and the acronym often modifies concepts such as investment returns, earnings and net pay. Year to Date (YTD) performance of Cara Therapeutics Inc. (NASDAQ:CARA) is 17.22 percent while its Performance (Week) is 4.91 percent and Performance (month) is at 10.33 percent.
Price Target Analysis:
According to the analysts, Cara Therapeutics Inc. (NASDAQ:CARA) currently has a Mean Price Target of $22.13. The Low and High Price targets are $17 and $30, respectively. These price targets are a consensus analysis of 8 brokers.
In order to reach an opinion/Recommendation the analyst research public financial statements, listen in on conference calls and talk to managers and the customers of a company, in attempt to capture the information for a research report. Based on this investigation into the company’s performance the analyst decides whether their stock is a “buy,” sell” or hold.
By looking at the Recommendation Trends of the stock polled by Thomson First call for the current month, 3 Analysts assigned the stock as Strong Buy. 5 said it’s a Buy, 0 assigned Hold rating where 0 stated the stock as Underperform and 0 marked the stock as Sell.
Earnings Estimate Analysis:
While looking at the Earnings Estimates of the company, The Average Earnings Estimate for the Current Fiscal quarter is measured as $-0.46 by 3 analysts. They are also projecting the Low EPS estimate as $-0.48 as compared to the Higher EPS estimate of $-0.44.